Background: Small airway hyperresponsiveness is a critical aspect in preschool children with asthmatic symptoms in terms of asthma control. The aim of this study was to elucidate the relationship of changes in reactance (Xrs) and resistance (Rrs) of IOS and FEV 1 with those in clinical parameters and to determine which IOS parameter is correlated with bronchial hyperresponsiveness before positive clinical endpoints.
Background
Measurements of bronchial hyperresponsiveness (BHR) have provided integral information for the diagnosis and management of lung diseases in children and adults. 1 Forced spirometry can be feasible in preschool children, allowing evaluations of bronchodilator response 2 and baseline lung function. However, young children lack the ability to tolerate the repetitive measurements of bronchial challenge testing with spirometry and thus hindering its clinical use. 3, 4 Therefore, other methods have been used clinically to assess bronchial hyperresponsiveness in preschool children, including the auscultation method,
Methods

Subjects
We enrolled children with asthmatic symptoms such as recurrent wheezing episodes (more than twice) diagnosed at least once at the Pediatric Allergy clinic of CHA Bundang Medical Center who showed a positive bronchodilator response or improvement after taking inhaled corticosteroid between June 2010 and May 2012. The family and personal medical history of each subject were based on questionnaires, physical examinations, and lung function tests.
Methacholine challenge testing
Bronchial challenge testing was performed with 5-step quadrupling concentration doses (0.0625, 0.25, 1, 4, and 16 mg/ mL methacholine dissolved in phosphate buffer). At each step, oxygen saturation, chest and tracheal auscultation, and subjective respiratory symptoms were checked by two experienced specialists and IOS pulmonary function tests were also performed. FEV 1 was measured by spirometry at baseline and at the end of the test due to concerns about exhaustion of the subject. IOS measurements were systematically taken prior to spirometry. The end point of a challenge for the EOT positive group (EOT + ) was defined as one or more of the following: (a) audible wheeze over the chest or trachea (provocation concentration of wheezing; PCW + ); (b) oxygen saturation below 91% (provocation concentration of saturation; PCS + ); or (c) respiratory symptoms such as persistent cough, shortness of breath, or tachypnea for which the children were unable to sustain the test (provocation concentration of respiratory symptoms; PCr + ). 4, 5 Subjects were defined as EOT negative (EOT − ) if they reached a methacholine concentration of 16 mg/mL without developing these manifestations. Each subject inhaledsolution for 1 minute using a nebulizer (DeVilbiss Health Care Inc., Somerset, PA) and a facemask, continuing every 5 minutes until the maximum concentration or end point was reached. 4 All children were asked to abstain from bronchodilators for at least 12 h before methacholine challenge. After the methacholine challenge test, 4 puffs of salbutamol with a spacer were administered to the child. This study was approved by the Institutional Review Board of the CHA Bundang Medical 13 Accordingly, studies using the oscillation technique to assess bronchial hyperresponsiveness in preschool children are increasing. 8, 14, 15 Clinical use of methacholine provocation testing with five sequential concentration is limited in young children due to difficulty of performing the challenge test correctly and the lack of criteria for positive test in differentiating the asthmatic children.
Therefore, the purpose of this study was to investigate the relationship of changes in reactance and resistance of IOS and FEV 1 with those in clinical endpoints such as oxygen saturation, auscultation and respiratory symptoms and to determine which IOS parameter is significantly correlated with bronchial hyperresponsiveness before positive clinical endpoints in preschoolers.
Center, CHA University School of Medicine. Written informed consent was obtained from the parents or guardians of all participants following a detailed explanation of the study.
IOS
IOS was performed 30, 60, and 90 seconds after methacholine inhalation in accordance with the ATS guidelines. For quality control, we monitored the visual acceptance of volume, flow and impedance traces. 2 Participants breathed tidally into the IOS mouthpiece for at least 30seconds.
Spirometry
Spirometry was performed using a Jaeger MasterScreen device (Jaeger CO, Wurzburg, Germany), according the ATS guidelines. 16 Spirometry results in these children were compared with those of healthy children by determining z-scores.
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Auscultation and saturation monitoring
Auscultation was performed independently by an experienced pulmonary technician and a pediatrician (Han MY) at baseline and at each inhalationstep. 18 The methacholine concentration at which wheezing was first heard clearly over the lung by both medical professionals was defined as the result of determination by auscultation (PCW + ). Oxygen saturation (SpO 2 ) was monitored using a finger oximeter (GO2, Nonin Medical Inc, Biox 3700e, Minnesota, USA). The percent reduction in oxygen saturation was calculated using the following formula: 100 × (baseline saturation -post saturation) / (baseline saturation). Changes in saturation were grouped as < 2% (S1), 2-3.9% (S2), 4-5.9% (S3), 6-7.9% (S4) and ≥ 8% (S5). The mean percent reduction in oxygen saturation during bronchial challenge was approximately 3%, included in the S2 group.
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Calculation of cumulative dose of methacholine
Methacholine chloride (Sigma Chemical, St. Louis, MO, USA) was inhaled usinga PARI BOY nebulizer (PARI GmbH, Starnberg, Germany), with a mean output of 0.20 ± 0.02 ml/ min. The dose response slope was defined as percent reduction in FEV 1 from baseline to the final dose of methacholine administered divided by the final cumulative dose. 20 Although bronchial hyperresponsiveness is usually confirmed by measuring PC 20 _FEV 1 , the provocative concentration causing a 20% fall in FEV 1 by spirometry, 21 we were not able to calculate PC 20 _FEV 1 accurately as FEV 1 was performed only at baseline and at the last step and described as dichotomy of positive or negative results. We therefore used the dose-response slope, 22, 23 PC 80 _Xrs 5 8,23,24 and PC 40 _Rrs 5 14,25,26 to compare bronchial hyperresponsiveness in our EOT + and EOT − groups. PC 80 _Xrs 5 and PC 40 _Rrs 5 positive means that the rate of change in the last step from baseline decreased by 80% or more in reactance and increased by 40% or more in resistance when measuring with IOS. The method of calculating DRS is briefly described as follows. 22, 23 We obtained the cumulative dose at each level expressed in micromoles as 0.014, 0.072, 0.302, 1.222, and 4.901 mmol, respectively, which were obtained using the molecular weight of methacholine chloride (195.7 g/ mol). The slope was defined as log (percent change in X/last cumulative dose), where X represents Rrs 5 , Xrs 5 , and FEV 1 .
Statistics
Continuous variables in the EOT + and EOT − groups were compared using the independent Student's t tests, and categorical variables were compared using the chi squared tests. Pearson correlation analysis was used to analyze changes in SpO 2 , Xrs 5 , and Rrs 5 . Analysis of variance testing with post hoc LSD analysis was used to assess differences among the S1~S5 groups. ROC curves were used to predict 80% changes in Xrs 5 at each step. All statistical analyses were performed with PASW statistical software (version 20.0; PASW Statistics; Chicago, IL, USA). All statistical tests were two-sided and statistical significance was defined as a P value < 0.05.
N = 94
Age, years (95%CI 
Results
Characteristics of subjects
The anthropometric data and baseline lung function of the subjects are presented in Table 1 . Of 94 preschool children, 92 children (98%; 52 boys, mean age 4.2 ± 1.1 years) performed technically acceptable IOS and 75 (80%, 42 boys, mean age 4.4 ± 1.0 years) performed technically acceptable spirometry; of the latter, three children completed baseline spirometry, but failed to perform spirometry at the last step. statistically different between groups, but the IOS test showed no significant difference except for DRS result ( Table 2) . Both DRS Xrs 5 (r = 0.864, P < 0.001) and DRS Rrs 5 (r = 0.836, P < 0.001) showed strong positive correlations with DRS FEV 1 (Figure 1) . Moreover, DRS of Rrs 5 and Xrs 5 were strongly correlated with each other (r = 0.911, P < 0.001). Figure 2 shows the relative changes of Xrs 5 ( Figure 2A ) and Rrs 5 ( Figure 2B ) according to the degree of changes in oxygen saturation. The mean baseline SpO 2 was 98.5 ± 0.69% (range 98.4-98.7%). There was a statistically significant difference between Xrs 5 and Rrs 5 among groups (P < 0.001). However, Xrs 5 showed a higher correlation with changes in saturation (r = -0.578, P < 0.001) than Rrs 5 (r = -0.426, P < 0.001). The adjusted R squared of Xrs 5 affecting SpO 2 in regression coefficients was 0.34 (P < 0.001), whereas the adjusted R squared of Rrs 5 was 0.18 (P < 0.298) ( 
Comparison of EOT
Changes in IOS parameters before EOT +
Since the parameters of IOS are susceptible to changes before the occurrence of airway obstruction, we assessed percent changes in lung function from baseline to Last-1 and Last-2 steps as well as the last step (Figure 3) . All parameters demonstrated significant changes when compared with the previous step (P < 0.001). Using ROC curves, we determined the relationship between the sensitivity and specificity in the percent change of Xrs 5 and Rrs 5 for predicting of PC 80 _Xrs 5 and PC 40 _Rrs 5 ( Figure  4) . The AUC of Xrs 5 (0.837, 95%CI 0.765-0.909) was larger than that for Rrs 5 (0.812, 95%CI 0.744-0.879). A forty-nine percent decrease in Xrs 5 was the optimal point of sensitivity (62.5%) and specificity (90.7%) for predicting a 80% change of Xrs 5 at the following step. The cutoff point of PC 40 _Rrs 5 was 19.1% with a lower sensitivity and specificity (31.6% and 68.4%, respectively) than those of reactance.
Discussion
In this study we measured the relative changes and Z scores of Xrs 5 and Rrs 5 when EOT was reached. We found that percent change of FEV 1 in preschool children was similar to that observed in previous studies with the presence of wheezing. 3, 4, 27 When the test was stopped due to respiratory symptoms, resistance did not exceed 40% and positive rate of PC 40 _Rrs 5 was even higher in EOT − group than that in EOT + group. Therefore, a 40% change in Rrs 5 may not be an appropriate parameter in bronchial challenge testing. The percent changes and Z scores of Xrs 5 better represent changes in saturation than percent changes and Z scores of Rrs 5 . Although FEV 1 and Xrs 5 reflect different pathophysiologic changes in the lungs, Xrs 5 showed good agreement with the decline in FEV 1 . 28 Because it is difficult to process the 10 steps of bronchoprovocation tests with doubling doses in preschool children, we suggest beginning the test by quadrupling doses and switching to doubling doses when 51.4% of Xrs 5 is reached.
In children with EOT + , they show higher changes than the reference values in most cases. 21, 24, 25 In addition, pulmonary function test was positive even when EOT was negative in many cases. With regard to resistance, positive rate of PC 40 _Rrs 5 was even higher in the EOT − group than that in the EOT + group. This suggests that even if the respiratory symptoms are absent, oxygen saturation is normal, or wheezing is not auscultated, the patient may already have bronchoconstriction and thus be in danger of developing respiratory difficulty in some cases. Therefore, these clinical parameters were not able to detect the pulmonary function changes at the early stage, and if these are Another limitation was the difficulty of defining EOT − due to lack of a healthy control group.
In the methacholine challenge test using IOS, which can be done more easily in preschooler than spirometry, reactance better reflects bronchial hyperresponsiveness than resistance. Therefore, we suggest switching to doubling doses when reactance reaches a certain level in order to minimize the risk of severe bronchoconstriction and increase the success rate.
used as a standard endpoint for the bronchial challenging test, the diagnosis of asthma may not be made accurately and be at risk sometimes.
Comparing Xrs 5 24 The parameters of IOS and spirometry reflect different properties of the respiratory system. 2 However, changes in IOS parameters are well correlated with those in FEV 1 in many studies. 7, 14, 23 As shown in our previous studies, we investigated which IOS parameter is more correlated with BHR and found that reactance better reflects BHR than resistance. We do not have clear explanation for this finding. Further research is warranted to describe the significant physiological correlation of reactance with BHR.
Since the respiratory symptoms and wheezing were not comparable with IOS parameters numerically during the examination, we compared the changes in oxygen saturation with parameters and reactance showed a more significant change with the saturation. Consequently, in preschoolers, reactance, rather than resistance, reflects bronchial hyperresponsiveness in methacholine challenge test. As we previously mentioned, the clinical parameters may lead to a dangerous situation in preschooler because most of cases have already exceeded the reference value when the test was completed and we found the reactance was a better parameter for determining the bronchial hyperresponsiveness. Therefore, we determined the optimal reactance value for examining carefully before proceeding the test by comparing the last step with the previous steps, and found that a 49% decrease in Xrs 5 indicated an 80% change in reactance at the following step. Thus, if the reactance decreases to near 49% in preschoolers during the methacholine test, we recommend lowering the concentration at the next step.
The appropriate increases in concentration during methacholine challenge testing have not been determined. Some recent studies reported that preschool children successfully completed methacholine challenge testing when concentrations were tripled. 29, 30 However, these studies are limited in that they included a small number of subjects and that the initial start-up concentration was relatively high, and the test time was short. In contrast, our study using methacholine in four fold increments had a lower success rate of spirometry, but the IOS success rate was even higher up to 98%. Therefore, we suggest that in the case of young preschoolers, the methacholine test using spirometry can be performed by raising the starting concentration and increasing the concentration by three or four times. It may also be useful to perform methacholine test using IOS due to the notion that IOS requires minimal patient cooperation. The risk of severe bronchoconstriction can be minimized by lowering the concentration when a certain change is observed in previous results. However, further research is needed to determine changes in lung function when apply doubling doses.
